Peng at al [38] reported that in addition to being upregulated in high-grade gliomas, CTHRC1 expression correlated with genes associated with the Wnt Signaling pathway (DVL3, DVL1, DVL2, ROR2, WNT3A, FZD6 and FZD5). The gene discussed is ROR2; the disease is central nervous system cancer.